The construction industry overuses natural resources and energy, causing numerous environmental impacts (ENSHASSI; KOCHENDOERFER; RIZQ, 2014; MORA-BARRANTES et al., 2018; AKINTAYO et al., 2020). The ...
"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
One of the industry’s leading large language models has passed a Turing test, a longstanding barometer for human-like intelligence. In a new preprint study awaiting peer review, researchers report ...
The creators of a new test called “Humanity’s Last Exam” argue we may soon lose the ability to create tests hard enough for A.I. models. Credit...Rune Fisker Supported by By Kevin Roose Reporting from ...
The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...
Failing a "sit-to-stand" or "sit-rise" test, which entails standing up from the floor with legs crossed, without using hands, arms, knees or side of the legs, means one has a higher likelihood of ...
The WIDA ACCESS language proficiency test is used across close to 40 states as part of the federal requirement to determine whether English learners continue to need language-development services. The ...
Schools are required to test the progress of their English learners each year to determine whether they still need language instruction services or can exit out of such programs. In close to 40 states ...
In a nutshell: Microsoft has rolled out a new update to its Edge browser, re-adding one notable feature removed from the software last year. Version 124.0.2478.80 sees the internet speed test return ...
Blue laser imaging vs white light imaging significantly improved sensitivity of real-time endoscopic diagnosis of H pylori infection. Upper gastrointestinal endoscopy is indicated for many patients ...
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results